Cancer Ranks Tenth in Causes of Death Among Indian Children: Lancet Study - Video

Childhood cancer remains a major public health challenge, ranking among the top ten causes of death in India, according to the Global Burden of Disease Study 2023 published in The Lancet. In 2023 alone, an estimated 17,000 children in India died from cancer, highlighting a significant and often underrecognized burden.

Globally, childhood cancer was the eighth-leading cause of death, surpassing diseases such as measles, tuberculosis, and HIV/AIDS. The study reported approximately 377,000 new cases and 144,000 deaths worldwide in 2023. The most common types included leukemias, brain and central nervous system cancers, and non-Hodgkin lymphoma.

Despite advances in treatment, disparities remain stark. Low- and middle-income countries accounted for 85% of new cases and a striking 94% of deaths and disability-adjusted life years (DALYs). DALYs reflect the total years of healthy life lost due to illness and premature death, underscoring the long-term impact of childhood cancer.

India’s burden may be even higher than reported. Experts estimate that between 50,000 and 75,000 children are diagnosed annually, suggesting underreporting and gaps in surveillance. While survival rates have improved significantly in high-income countries, many children in Low- and middle-income countries face delays in diagnosis, limited access to treatment, and inadequate healthcare infrastructure.

Encouragingly, childhood cancers are often highly treatable, especially when detected early. However, improving outcomes requires systemic changes. These include strengthening referral systems, expanding access to chemotherapy, surgery, and radiotherapy, and improving workforce training and cancer registries.

The findings highlight an urgent need for targeted policy action. Investments in comprehensive cancer care systems, particularly in resource-limited settings, could significantly reduce mortality. Bridging the gap between high- and low-income regions is critical to ensuring that advances in treatment benefit all children equally.

REFERENCE: Force L, Kocarnik J, May M et al.; Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet; DOI: 10.1016/S0140-6736(26)00200-X External Link